Condition: Total Knee Replacement Surgery · Post-operative Pain · Sponsor: Icahn School of Medicine at Mount Sinai
This is a prospective, randomized study. The purpose of this study is to evaluate if the addition of Suzetrigine, a new pain medication, to well established peri-operative pain regimen used for total knee replacement surgery will effect pain control. 1. Does Suzetrigine given pre-operatively decrease the total opioid consumed after total knee replacement surgery? 2. Dose Suzetrigine given pre-operatively decrease the visual analog pain scale pain scores after total knee replacement surgery? Study participants will be randomly assigned to receive either Suzetrigine medication or placebo medication.
This description comes directly from the study's public registry record.
Michael Lazar, MD · 212-523-2500 · michael.lazar@mountsinai.org
Himani Bhatt, DO · 212-523-2500 · himani.bhatt@mountsinai.org
Always discuss trial participation with your own doctor first.
| Mount Sinai West | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07548385